The Incidence and Impact of In-Hospital Bleeding in Patients with Acute Coronary Syndrome during the COVID-19 Pandemic
- Roberto Licordari
- Alessandro Sticchi
- Filippo Mancuso
- Alessandro Caracciolo
- Saverio Muscoli
- Fortunato Iacovelli
- Rossella Ruggiero
- Alessandra Scoccia
- Valeria Cammalleri
- Marco Pavani
- Marco Loffi
- Domenico Scordino
- Jayme Ferro
- Andrea Rognoni
- Andrea Buono
- Stefano Nava
- Stefano Albani
- Iginio Colaiori
- Filippo Zilio
- Marco Borghesi
- Valentina Regazzoni
- Stefano Benenati
- Fabio Pescetelli
- Vincenzo De Marzo
- Antonia Mannarini
- Francesco Spione
- Doronzo Baldassarre
- Michele De Benedictis
- Roberto Bonmassari
- Gian Battista Danzi
- Mario Galli
- Alfonso Ielasi
- Giuseppe Musumeci
- Fabrizio Tomai
- Vincenzo Pasceri
- Italo Porto
- Giuseppe Patti
- Gianluca Campo
- Antonio Colombo
- Antonio Micari
- Francesco Giannini
- Francesco Costa
DOIAbstract
Background: The COVID-19 pandemic increased the complexity of the clinical management and pharmacological treatment of patients presenting with an Acute Coronary Syndrome (ACS). Aim: to explore the incidence and prognostic impact of in-hospital bleeding in patients presenting with ACS before and during the COVID-19 pandemic. Methods: We evaluated in-hospital Thrombolysis In Myocardial Infarction (TIMI) major and minor bleeding among 2851 patients with ACS from 17 Italian centers during the first wave of the COVID-19 pandemic (i.e., March–April 2020) and in the same period in the previous two years. Results: The incidence of in-hospital TIMI major and minor bleeding was similar before and during the COVID-19 pandemic. TIMI major or minor ble...
Add to ORKG